A potential role for centrosomal deregulation within IgH translocation-positive myeloma

Medical Hypotheses

Volumn 65, Issue 5, 2005, Pages 915-921

  Maxwell, Christopher A ^a   Pilarski, Linda M ^b  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; GENE PRODUCT; IMMUNOGLOBULIN HEAVY CHAIN; CYCLINE; PARAPROTEIN;

ARTICLE; CARCINOGENESIS; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME 13; CHROMOSOME ABERRATION; CHROMOSOME DELETION 13; CHROMOSOME TRANSLOCATION; GENE TARGETING; MITOSIS SPINDLE; MULTIPLE MYELOMA; MYELOMA; PRIORITY JOURNAL; ANIMAL; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; HUMAN; METABOLISM; MUTATION;

ANIMALS; CENTROSOME; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; MUTATION; MYELOMA PROTEINS; TRANSLOCATION, GENETIC;

EID: 27244432264     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.05.031     Document Type: Article

References (53)

1. R. Fonseca Genetics and cytogenetics of multiple myeloma: a workshop report Cancer Res 64 2004 1546 1558
2. T. Hideshima, P.L. Bergsagel, W.M. Kuehl, and K.C. Anderson Advances in biology of multiple myeloma: clinical applications Blood 104 2004 607 618
3. W.M. Kuehl, and P.L. Bergsagel Multiple myeloma: evolving genetic events and host interactions Nat Rev Cancer 2 2002 175 187
4. J.J. Keats In multiple myeloma t(4;14) (p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression Blood 101 2003 1520 1529
5. M. Santra, F. Zhan, E. Tian, B. Barlogie, and J. Shaughnessy Jr. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript Blood 101 2003 2374 2376
6. E.M. Hurt Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma Cancer Cell 5 2004 191 199
7. C.H. Spruck, K.A. Won, and S.I. Reed Deregulated cyclin E induces chromosome instability Nature 401 1999 297 300
8. J. Lamb A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer Cell 114 2003 323 334
9. R. Fonseca The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma Blood 102 2003 2562 2567
10. E.A. Nigg Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2 2002 815 825
11. H. Zhou Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation Nat Genet 20 1998 189 193
12. E.W. Verschuren, J. Klefstrom, G.I. Evan, and N. Jones The oncogenic potential of Kaposi's sarcoma-associated herpesvirus cyclin is exposed by p53 loss in vitro and in vivo Cancer Cell 2 2002 229 241
13. G. Sluder, and J.J. Nordberg The good, the bad and the ugly: the practical consequences of centrosome amplification Curr Opin Cell Biol 16 2004 49 54
14. N.J. Quintyne, J.E. Reing, D.R. Hoffelder, S.M. Gollin, and W.S. Saunders Spindle multipolarity is prevented by centrosomal clustering Science 307 2005 127 129
15. Q. Wang The centrosome in normal and transformed cells DNA Cell Biol 23 2004 475 489
16. C.A. Maxwell, J.J. Keats, A.R. Belch, L.M. Pilarski, and T. Reiman Receptor for hyaluronan mediated motility (RHAMM) correlates with centrosomal abnormalities and maintains mitotic integrity Cancer Res 65 2005 850 860
17. C.A. Maxwell RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma Blood 104 2004 1151 1158
18. C.A. Maxwell RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability Mol Biol Cell 14 2003 2262 2276
19. G.R. Boersma-Vreugdenhil The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint Br J Haematol 126 2004 355 363
20. K. Neben Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes Oncogene 23 2004 2379 2384
21. S.P. Blagden, and D.M. Glover Polar expeditions - provisioning the centrosome for mitosis Nat Cell Biol 5 2003 505 511
22. P. Meraldi, R. Honda, and E.A. Nigg Aurora kinases link chromosome segregation and cell division to cancer susceptibility Curr Opin Genet Dev 14 2004 29 36
23. J.W. Raff Centrosomes and cancer: lessons from a TACC Trends Cell Biol 12 2002 222 225
24. M. Roh Overexpression of the oncogenic kinase Pim-1 leads to genomic instability Cancer Res 63 2003 8079 8084
25. N. Bhattacharya Pim-1 associates with protein complexes necessary for mitosis Chromosoma 111 2002 80 95
26. H. Katayama Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 Nat Genet 36 2004 55 62
27. S.S. Chen, P.C. Chang, Y.W. Cheng, F.M. Tang, and Y.S. Lin Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function Embo J 21 2002 4491 4499
28. O.J. Gruss, and I. Vernos The mechanism of spindle assembly: functions of Ran and its target TPX2 J Cell Biol 166 2004 949 955
29. M.Y. Tsai A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly Nat Cell Biol 5 2003 242 248
30. R. Giet Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules J Cell Biol 156 2002 437 451
31. T.A. Kufer Human TPX2 is required for targeting Aurora-A kinase to the spindle J Cell Biol 158 2002 617 623
32. A.C. Groen XRHAMM functions in ran-dependent microtubule nucleation and pole formation during anastral spindle assembly Curr Biol 14 2004 1801 1811
33. J. Jacquemier Protein expression profiling identifies subclasses of breast cancer and predicts prognosis Cancer Res 65 2005 767 779
34. S. Kammerer Association of the NuMA region on chromosome 11q13 with breast cancer susceptibility Proc Natl Acad Sci USA 102 2005 2004 2009
35. J. Ota Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders Oncogene 22 2003 5720 5728
36. A. Valdman, X. Fang, S.T. Pang, P. Ekman, and L. Egevad Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer Prostate 60 2004 367 371
37. R. Heald, and E. Nogales Microtubule dynamics J Cell Sci 115 2002 3 4
38. H.M. Kluger cDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model Lab Invest 84 2004 320 331
39. E.C. Yang Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10 J Proteome Res 3 2004 636 643
40. E.E. Solomou 13q deletion in chronic lymphocytic leukemia: characterization of E4.5, a novel chromosome condensation regulator-like guanine nucleotide exchange factor Leuk Lymphoma 44 2003 1579 1585
41. H. Mabuchi Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia Cancer Res 61 2001 2870 2877
42. M.C. Devilder cDNA cloning, gene characterization and 13q14.3 chromosomal assignment of CHC1-L, a chromosome condensation regulator-like guanine nucleotide exchange factor Genomics 54 1998 99 106
43. J.J. Keats Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32) positive multiple myeloma patients: analysis of the protein products Blood 105 2005 4060 4069
44. J.P. Stewart Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma Br J Haematol 126 2004 72 76
45. J. Jiang Identification of two novel human dynein light chain genes, DNLC2A and DNLC2B, and their expression changes in hepatocellular carcinoma tissues from 68 Chinese patients Gene 281 2001 103 113
46. P. Taimen, M. Viljamaa, and M. Kallajoki Preferential expression of NuMA in the nuclei of proliferating cells Exp Cell Res 256 2000 140 149
47. R.P. Piekorz The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis Embo J 21 2002 653 664
48. F. Zhan Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells Blood 99 2002 1745 1757
49. J.L. Harousseau, J. Shaughnessy Jr., and P. Richardson Multiple myeloma Hematology (Am Soc Hematol Educ Program) 2004 237 256
50. K.C. Anderson Clinical update: novel targets in multiple myeloma Semin Oncol 31 2004 27 32 discussion 33
51. A.G. Ehrhardt, and G. Sluder Spindle pole fragmentation due to proteasome inhibition J Cell Physiol 2005
52. J.L. Badano, T.M. Teslovich, and N. Katsanis The centrosome in human genetic disease Nat Rev Genet 6 2005 194 205
53. M. Ouchi BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition J Biol Chem 279 2004 19643 19648